In this ISSUE

Are Clinical Trial Data Shared by the EMA Under Policy 0070 Really Public Data?

Hope. The Power for the Rare Disease Journey

BlockChain in Clinical Trials—the Ultimate Data Notary

mHealth

Oracle Pursues mHealth in Clinical Trials

In this interview, Jim Streeter, Global Vice President of Life Sciences Product Strategy at Oracle, will elaborate further on Oracle's strategy with mHealth in clinical trials.
... /Read more/

Debunking the Myths of Risk-Based Monitoring for a New Approach to Quality Management
On Demand

Learn more

Patient Centricity

Direct-to-Patient Trials: Address Your Audience

CBI Conference Producer, Trevor Sosvielle, recently sat down with Matthew Amsden, CEO of ProofPilot to discuss his early work in HIV prevention trials. Amsden shares how these experiences helped shape ProofPilot and its patient-centric clinical trial approach.
... /Read more/

Calendar

/ Direct-to-Patient Clinical Trials /

/ American Pharma Outsourcing Summit 10/2-10/3 /

/ Crossroads: An Artia Solutions Conference 11/7-11/9 /

Ask the editor

Lisa Henderson
Editor-in-Chief
Lisa.Henderson@ubm.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com

Therapeutic Areas

CROs Tackle Neurodegenerative Disease Studies

In this interview, Linda Rawlings, VP of Neurodegenerative Development at Synteract, elaborates on addressing the challenges of neurodegenerative disease clinical trials.
... /Read more/

EU Vaccine

Policy and Practice Come Together on EU Vaccine Thrust

Peter O'Donnell explores the convergence of policy and science in new vaccine R&D pursuits in Europe.
... /Read more/

Clinical Operations

Clinical Trial Evolution: A CRO's Perspective

Leader of one longtime CRO discusses the marked changes in clinical trial practice from past to present—and the company's unique focus.
... /Read more/

website / blog / advertise / subscribe